Background of Study

The Fundamental Review of the Trading Book (FRTB) requires banks to make a more rigorous assessment of their exposure to market risk, including new eligibility tests for risk factors used (RFET) to derive capital requirements under a revised Internal Model Approach (IMA).

With changing deadlines for compliance and varying local interpretations, firms continue to struggle with the complexity of the guidelines under fluctuating budgets.

A leading tier 1 bank looked for an agile yet robust solution that would help them gain insight on and build their internal business case for FRTB IMA. This both supported regulatory QIS and refined their business and infrastructure strategies ahead of regulatory go-live.

“We rolled out a full scale QIS capability in 2 months delivered the business case 9-12 months earlier than with an internal build model.”

Pain Points

The bank’s risk management team needed to build out an FRTB-ready risk infrastructure in a timely manner and with budgetary constraints. In particular they needed to:

  • Reduce the total cost of ownership of their FRTB infrastructure and shorten time to delivery both for programmes and QIS
  • Gain visibility on the capital impact of new trades, model assumptions and changing market conditions
  • Manage exposure and resulting market risk capital requirements more effectively
  • Hedge their implementations against global or local regulatory updates

The risk management team were aware that S&P Global Market Intelligence is a leading provider of traded market risk solutions and contacted us to learn more about the offering.

The Solution

S&P Global Market Intelligence specialists first described the Traded Market Risk solution, which combines market-leading data with cutting-edge analytics in a hosted service delivered by a team of subject matter experts. The specialists described how the solution can enable compliance with the Basel market risk requirements whilst reducing the impact, cost and complexity of market risk projects.

For FRTB more specifically, the solution delivers IMA and SA capital management through to IMA specific requirements of passing the Risk Factor Eligibility Test (RFET), ES vs SES scenario generation and NMRF proxying.

Under volatile market conditions, banks can leverage our pre-populated, extensive RPO datasets delivering realistic and actionable RFET results. These datasets, updated daily, drove pro-active investigations across interest rate, fixed income, credit, equity or FX derivatives depending on portfolio composition. As one user commented, “it was very easy to demonstrate the benefit of S&P curated RPO data sets on IMA capital”.

Whilst many banks have similar broad RFET definitions, the consequences of risk factor observability translate very differently in IMA capital terms on individual portfolios. Using our Traded Market Risk solution, risk quants could measure the capital impact of a change in modellability mapping assumption and NMRF proxy decision in a matter of minutes using its sensitivity-based capital what-if capability. This gave the bank a powerful decision-making tool to inform day-to-day project activities. This in turn drove buy-in from senior management as well as regulators and enabled the bank to run multiple capital scenarios concurrently with minimal impact on their existing infrastructure.

FRTB RFET/Modellability showing the OIS curves transition to RFR

Figure 1: FRTB RFET/Modellability showing the OIS curves transition to RFR

Other FRTB teams using our Traded Market Risk solution have also built rapid insight into IMA vs SA benefits and key focus areas for data and model fine-tuning by leveraging our agile self-service configuration capability. This has helped shape regulatory interactions and maximise value under growing budget constraints, while educating internal stakeholders and regulators alike on their model assumptions and capital analyses.

“The bank was able to increase modellable risk factors eligible for ES models under IMA by 40% on average.”

Project Outcomes and Benefits

Awards Received

chartis-risktech-100-2024
sell-side-technology
risktech-100-2023
asiarisk-awards
risktech-100-2022-model-validation
risktech-100-2022

Future proof your market risk capabilities with our multi award winning Traded Market Risk management solution.

Related Products

Related Thought Leadership